NAUT
NASDAQ · Life Sciences Tools & Services
Nautilus Biotechnology Inc
$2.51
-0.11 (-4.20%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+958.2% upside
Low Target
$24.26
Average Target
$26.56
High Target
$41.87
Current Price
$2.51
Current
$2.51
$2.51
Target
$26.56
$26.56
$24.26
$26.56 avg
$41.87
Scenario Analysis
Bear Case
$24.26
866.5%
Low target
Base Case
$26.56
+958.2%
Avg target
Bull Case
$41.87
+1,568.1%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$4.31
-41.8% from high
52-Week Low
$0.62
+304.8% from low
Target vs 52W High
$26.56
+516.2% vs high
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 34 | 88% | $369.21 | -17.3% |
| DHR | Strong Buy | 30 | 87% | $158.11 | -5.3% |
| WAT | Buy | 28 | 57% | $189.60 | -43.1% |
| A | Strong Buy | 28 | 79% | $64.69 | -41.5% |
| IQV | Strong Buy | 31 | 87% | $82.96 | -52.1% |
| ILMN | Hold | 28 | 54% | $169.36 | +19.5% |
| WST | Strong Buy | 23 | 78% | $136.24 | -55.0% |
| MTD | Hold | 21 | 48% | $170.43 | -84.2% |